Objective: To evaluate efficacy, durability, and safety of next-generation chimeric antigen receptor T-cell therapies in relapsed or refractory acute lymphoblastic leukemia. Design: A systematic revie

The term "brain diabetes or type 3 diabetes" has begun to be used by researchers targeting the possible link between AD and T2 diabetes mellitus (DM). The main reason for using this term is to emphasi